American Regent, Inc.
Clinical trials sponsored by American Regent, Inc., explained in plain language.
-
Experimental drug shows promise for rare eye cancer
Disease control CompletedThis study tested a weekly dose of a chemotherapy drug called Taxoprexin in 22 people with advanced eye melanoma that had spread to other parts of the body. The goal was to see if the drug could shrink tumors and how long that effect might last. Researchers also tracked side effe…
Phase: PHASE2 • Sponsor: American Regent, Inc. • Aim: Disease control
Last updated May 26, 2026 06:48 UTC
-
New drug shows promise for advanced skin cancer
Disease control CompletedThis study tested a weekly dose of a new chemotherapy drug called Taxoprexin in 30 people with advanced melanoma that had spread to other parts of the body. The goal was to see if the drug could shrink tumors and how long that effect might last. Researchers also tracked side effe…
Phase: PHASE2 • Sponsor: American Regent, Inc. • Aim: Disease control
Last updated May 26, 2026 06:42 UTC